Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$401K Buy
5,046
+1,922
+62% +$140K 0.01% 664
2021
Q4
$229K Sell
3,124
-98
-3% -$6.61K 0.01% 1012
2021
Q3
$222K Buy
3,222
+157
+5% +$11.9K 0.01% 1031
2021
Q2
$258K Buy
3,065
+104
+4% +$8.67K 0.01% 1002
2021
Q1
$241K Buy
2,961
+376
+15% +$32.1K 0.01% 990
2020
Q4
$225K Buy
2,585
+1,219
+89% +$105K 0.01% 863
2020
Q3
$123K Buy
1,366
+824
+152% +$79.5K 0.01% 897
2020
Q2
$56K Buy
542
+479
+760% +$46.2K ﹤0.01% 919
2020
Q1
$5K Buy
63
+1
+2% +$76 ﹤0.01% 887
2019
Q4
$5K Buy
+62
New +$5.3K ﹤0.01% 728

Other funds holding INCY

IndexIQ Advisors's INCY Position: Q1 2022 in Review

IndexIQ Advisors increased its Incyte (INCY) stake by 62% in Q1 2022, buying an estimated $140K and bringing the position to 5,046 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #664.

IndexIQ Advisors first reported a position in INCY in Q4 2019 and has held it in 10 quarters since. 533 funds tracked by Wall St. Rank hold INCY as of Q1 2022.

  • IndexIQ Advisors held 5,046 shares of Incyte worth $401K as of Q1 2022.
  • IndexIQ Advisors bought 1,922 Incyte shares in Q1 2022, an estimated $140K.
  • Incyte made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #664 holding.
  • IndexIQ Advisors first reported a position in Incyte in Q4 2019 and has held it in 10 quarters since.
  • 533 funds tracked by Wall St. Rank held Incyte as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.